Researchers uncover the source of cells that contribute to pulmonary fibrosis
Researchers have been trying for decades to stop the cells that damage the lung in people with pulmonary fibrosis. Now a team ...
MyChesCo on MSN9d
Savara Inc. Publishes Promising Long-Term Outcomes for aPAP Treatment
LANGHORNE, PA — Savara Inc. (Nasdaq: SVRA) has announced the publication of a manuscript detailing long-term outcomes for molgramostim inhalation solution in patients with autoimmune pulmonary ...
Students possibly exposed to tuberculosis at South Bay school: county officials
County health officials are warning of a possible tuberculosis exposure for students, employees and others who may have entered a South Bay school from Feb. 24 to June 5, 2024.
Your wood burner could be as bad for you as smoking
A study found that burning wood in our homes is one of the most dangerous types of air pollution. Here’s what you need to ...
Molgramostim shows promise in rare lung disease treatment
LANGHORNE, Pa. - Savara Inc. (NASDAQ:SVRA), a biopharmaceutical company specializing in rare respiratory diseases with a ...
Alpha Tau announces interim data from pembrolizumab combination trial
The company announced interim data showing strong systemic responses in its safety and efficacy study combining Alpha DaRT treatment with ...
tunnellingjournal21d
Herrenknecht delivers E-Power Pipe machine
December saw Herrenknecht hand over an E-Power Pipe machine to Heitkamp Construction Swiss GmbH for use – among other ...
The EMBO Journal26d
A novel human fetal lung-derived alveolar organoid model reveals mechanisms of surfactant protein C maturation relevant to interstitial lung disease
Alveolar type 2 (AT2) cells maintain lung health by acting as stem cells and producing pulmonary surfactant. AT2 dysfunction underlies many lung diseases, including interstitial lung disease (ILD), in ...